Cryptocurrencies
Eli Lilly leaps as weight-loss-drug sales drive earnings and 2024 outlook
Updated at 7:47 AM EST Eli Lilly (LLY) – Get Free Report posted better-than-expected fourth-quarter earnings Tuesday, while issuing a robust near-term outlook, thanks in part to surging sales of its diabetes and weight-loss treatments, which Read more…